In both NPC lines, phosphorylated SMAD3 was initially more nuclear at baseline than total SMAD3, and while it increased in the nuclei of Q21 cells, this effect was less clear in Q109 cells; although this again appeared to be due to high variability between individual cells (Fig. 5). This evidence concerns the gene SMAD3 and nasopharyngeal carcinoma.